CancerX shared on LinkedIn:
”Committed champions. Global founders. Working together for patients.
The CancerX Accelerator connects early-stage oncology startups with leading health systems, pharma, payers, and investors like Advocate Health, Moffitt Cancer Center, Novartis, Johnson and Johnson, and Oncology Ventures to solve some of cancer care’s most urgent challenges.
- 100% of startups in our most recent cohort left with at least one potential pilot opportunity
- 40+ startups have reached commercial milestones through the program
- No equity taken. No fees charged.
Join our next info session:
July 22, 2026 | 12:00 PM ET
Applications for the 2027 CancerX Accelerator Cohort open on July 31, 2026.
If you’re building the future of cancer care, we’d love to meet you.”
Read more articles about CancerX on OncoDaily.